Sumitomo Pharma Co., Ltd.

    Jurisdiction
    Japan
    LEI
    529900D60UKVYLJ2OJ79
    ISIN
    JP3495000006 (4506.T)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €13.93 32.7% undervalued
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Read full profile

    Fundamentals

    Net revenue
    €2.30B
    Gross margin
    61.5%
    EBIT
    €166.30M
    EBIT margin
    7.2%
    Net income
    €136.53M
    Net margin
    5.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €2.41B +4.7% €381.08M +179.1%
    €2.73B +13.3% €409.82M +7.5%
    €2.70B -1.2% €255.46M -37.7%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    ¥7.00
    Ex date
    Payment date
    Dividend payout ratio
    0.0%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications